HSPA4 and breast cancer: Furthermore, our findings revealed opposing abundance levels of some of the identified proteins in the PBMCs of primary and metastatic BC patients; HSPA4 and CANX had a significantly high abundance level in patients at both primary and metastatic stages, while the remaining proteins were downregulated in the patient's PBMCs at the primary stage, which were in contrast to the metastatic stage.